av/fresenius-medical-care--big.svg

COM:FRESENIUSMEDICALCARE

Fresenius Medical Care

  • Stock

Last Close

41.44

22/11 16:35

Market Cap

10.62B

Beta: -

Volume Today

373.72K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
789.24M
-
855.94M
8.45%
1.07B
25.23%
1.28B
19.74%
1.32B
2.51%
1.38B
4.80%
1.57B
13.51%
1.78B
13.69%
1.97B
10.53%
2.17B
10.19%
2.24B
3.26%
average payables
523.25M
-
534.89M
2.22%
650.65M
21.64%
777.88M
19.55%
789.69M
1.52%
766.45M
2.94%
815.12M
6.35%
831.29M
1.98%
842.46M
1.34%
894.43M
6.17%
908.24M
1.54%
average receivables
2.61B
-
2.98B
14.13%
3.56B
19.37%
3.97B
11.63%
3.92B
1.32%
3.73B
4.88%
3.87B
3.66%
3.79B
1.89%
3.76B
0.82%
3.97B
5.48%
4.05B
1.94%
book value per share
22.01
-
27.28
23.92%
31.53
15.61%
35.63
12.99%
35.32
0.87%
42.09
19.16%
43.70
3.82%
41.93
4.04%
47.72
13.79%
52.68
10.40%
capex per share
-1.78
-
-5.04
182.56%
-5.67
12.60%
-6.35
11.95%
-5.82
8.31%
-6.72
15.41%
-7.39
10.02%
-7.10
3.96%
-5.75
19.09%
-4.81
16.25%
capex to depreciation
-1.15
-
-2.65
129.63%
-2.63
0.62%
-2.63
0.06%
-2.43
7.95%
-2.84
17.16%
-1.40
50.56%
-1.17
16.78%
-1.04
11.34%
-0.77
25.95%
-0.39
49.09%
capex to operating cash flow
-0.37
-
-1.00
170.74%
-0.96
3.21%
-0.95
0.94%
-0.81
14.66%
-1.00
22.68%
-0.87
12.73%
-0.49
43.42%
-0.68
37.08%
-0.65
3.70%
-0.26
60.00%
capex to revenue
-0.05
-
-0.12
128.50%
-0.11
3.57%
-0.11
1.07%
-0.10
11.96%
-0.12
24.03%
-0.13
2.86%
-0.12
8.70%
-0.10
18.30%
-0.07
23.85%
-0.04
51.62%
cash per share
1.63
-
2.18
34.02%
2.47
13.15%
3.15
27.46%
3.20
1.77%
7.33
128.81%
3.77
48.54%
4.23
12.15%
5.52
30.64%
4.92
10.86%
days of inventory on hand
40.57
-
37.58
7.37%
42.90
14.17%
42.42
1.12%
39.99
5.72%
47.00
17.51%
50.25
6.93%
56.14
11.72%
59.31
5.64%
59.49
0.31%
54.75
7.98%
days payables outstanding
24.65
-
24.05
2.43%
24.99
3.90%
26.63
6.58%
22.86
14.15%
25.47
11.42%
25.23
0.94%
24.51
2.87%
24.96
1.82%
24.13
3.31%
22.24
7.84%
days sales outstanding
91.27
-
93.08
1.98%
90.63
2.63%
88.91
1.90%
75.87
14.67%
83.06
9.48%
82.90
0.20%
73.97
10.77%
80.93
9.42%
75.86
6.27%
76.19
0.43%
debt to assets
0.36
-
0.37
2.88%
0.34
9.60%
0.32
6.02%
0.31
2.59%
0.29
7.24%
0.42
45.52%
0.39
6.64%
0.39
0.79%
0.37
4.65%
0.36
3.89%
debt to equity
0.91
-
0.95
4.28%
0.82
13.34%
0.75
9.18%
0.69
8.06%
0.58
14.96%
1.04
78.15%
1.00
3.65%
0.95
5.09%
0.86
10.24%
0.88
3.45%
dividend yield
0.01
-
0.01
2.46%
0.01
27.22%
0.01
5.30%
0.01
2.94%
0.02
67.85%
0.02
4.05%
0.02
1.42%
0.02
33.89%
0.04
88.20%
earnings yield
0.05
-
0.05
10.14%
0.04
13.46%
0.05
20.81%
0.05
0.05%
0.11
135.20%
0.06
46.79%
0.06
3.43%
0.06
0.26%
0.08
29.68%
enterprise value
21.32B
-
26.02B
22.04%
31.07B
19.42%
32.04B
3.11%
33.12B
3.39%
22.95B
30.72%
32.74B
42.68%
31.35B
4.24%
28.58B
8.85%
20.90B
26.85%
10.65B
49.07%
enterprise value over ebitda
10.03
-
10.42
3.83%
10.75
3.16%
9.74
9.38%
10.55
8.29%
7.40
29.83%
14.22
92.12%
13.54
4.73%
14.85
9.61%
13.23
10.88%
3.10
76.60%
ev to operating cash flow
14.47
-
17.00
17.51%
17.33
1.95%
15.74
9.15%
15.11
4.03%
11.13
26.35%
12.75
14.61%
7.41
41.93%
11.48
55.01%
9.65
15.98%
4.05
58.01%
ev to sales
2.01
-
2.00
0.82%
2.03
1.56%
1.88
7.31%
1.86
0.99%
1.39
25.54%
1.87
35.09%
1.76
6.29%
1.62
7.61%
1.08
33.56%
0.55
49.21%
free cash flow per share
3.07
-
0.02
99.20%
0.22
783.65%
0.30
40.89%
1.33
335.62%
0.01
99.51%
1.09
16,559.25%
7.29
571.12%
2.75
62.28%
2.58
6.30%
free cash flow yield
0.06
-
0.00
99.33%
0.00
603.12%
0.00
36.13%
0.02
303.10%
0.00
99.25%
0.02
14,356.87%
0.11
549.08%
0.05
54.98%
0.08
75.14%
graham net net
-23.03
-
-30.01
30.26%
-31.33
4.42%
-32.62
4.11%
-28.70
12.02%
-24.59
14.33%
-48.76
98.31%
-49.15
0.81%
-50.59
2.94%
-50.09
0.99%
graham number
36.20
-
41.77
15.38%
46.83
12.14%
55.67
18.86%
57.60
3.48%
78.25
35.84%
62.43
20.21%
61.11
2.11%
59.59
2.49%
52.16
12.48%
income quality
1.62
-
1.48
8.86%
1.49
1.07%
1.38
7.45%
1.41
2.10%
0.93
34.33%
1.78
92.58%
2.95
65.36%
2.04
30.78%
2.42
18.58%
5.27
117.58%
intangibles to total assets
0.54
-
0.55
2.09%
0.54
0.97%
0.54
0.75%
0.53
1.23%
0.49
7.70%
0.47
4.54%
0.45
3.50%
0.46
1.73%
0.48
5.17%
0.47
2.52%
interest coverage
5.04
-
4.56
9.64%
4.58
0.55%
5.82
27.13%
5.95
2.17%
6.78
13.98%
1.45
78.68%
1.29
10.77%
0.85
33.84%
-0.72
184.08%
4.46
720.80%
interest debt per share
21.13
-
27.27
29.07%
27.50
0.84%
28.07
2.05%
25.59
8.82%
26.08
1.91%
47.16
80.82%
43.50
7.76%
46.67
7.31%
46.28
0.84%
inventory turnover
9.00
-
9.71
7.96%
8.51
12.41%
8.60
1.14%
9.13
6.06%
7.77
14.90%
7.26
6.48%
6.50
10.49%
6.15
5.34%
6.14
0.30%
6.67
8.67%
invested capital
0.91
-
0.95
4.28%
0.82
13.34%
0.75
9.18%
0.69
8.06%
0.58
14.96%
1.04
78.15%
1.00
3.65%
0.95
5.09%
0.86
10.24%
0.88
3.45%
market cap
15.72B
-
18.70B
18.98%
23.66B
26.55%
24.60B
3.94%
26.65B
8.36%
17.55B
34.17%
19.97B
13.79%
20.05B
0.45%
16.74B
16.53%
8.96B
46.44%
net current asset value
-5.32B
-
-7.15B
34.36%
-7.37B
3.02%
-7.76B
5.38%
-6.82B
12.09%
-5.49B
19.49%
-12.54B
128.35%
-12.08B
3.67%
-12.42B
2.80%
-12.10B
2.57%
-10.40B
14.05%
net debt to ebitda
2.64
-
2.93
11.14%
2.56
12.57%
2.26
11.71%
2.06
8.92%
1.74
15.45%
5.55
218.53%
4.88
12.01%
6.15
26.01%
7.56
22.87%
3.10
59.02%
net income per share
2.65
-
2.84
7.44%
3.09
8.77%
3.87
25.04%
4.18
8.01%
6.47
54.85%
3.96
38.68%
3.96
0.15%
3.31
16.44%
2.29
30.62%
operating cash flow per share
4.85
-
5.06
4.36%
5.89
16.33%
6.66
13.02%
7.15
7.44%
6.73
5.92%
8.48
26.07%
14.40
69.74%
8.50
40.98%
7.39
13.03%
payables turnover
14.81
-
15.18
2.49%
14.61
3.75%
13.71
6.17%
15.97
16.48%
14.33
10.25%
14.46
0.95%
14.89
2.96%
14.63
1.79%
15.13
3.42%
16.41
8.51%
receivables turnover
4.00
-
3.92
1.94%
4.03
2.70%
4.11
1.93%
4.81
17.20%
4.39
8.66%
4.40
0.20%
4.93
12.07%
4.51
8.61%
4.81
6.69%
4.79
0.43%
research and ddevelopement to revenue
0.01
-
0.01
10.51%
0.01
8.54%
0.01
8.14%
0.01
18.56%
0.01
9.94%
0.01
18.70%
0.01
13.01%
0.01
15.47%
0.01
5.88%
0.01
1.02%
return on tangible assets
0.10
-
0.09
12.33%
0.09
3.00%
0.10
13.50%
0.11
13.81%
0.15
30.34%
0.07
53.79%
0.07
2.21%
0.05
22.13%
0.04
30.16%
0.03
23.68%
revenue per share
34.82
-
43.06
23.66%
50.29
16.78%
55.70
10.76%
58.01
4.15%
53.98
6.95%
57.74
6.96%
60.73
5.19%
60.14
0.97%
66.15
9.98%
roe
0.12
-
0.10
13.30%
0.10
5.92%
0.11
10.66%
0.12
8.96%
0.15
29.95%
0.09
40.94%
0.09
4.05%
0.07
26.57%
0.04
37.16%
0.04
15.90%
roic
0.09
-
0.08
9.31%
0.08
4.66%
0.09
10.87%
0.10
9.42%
0.12
20.81%
0.02
85.52%
0.02
11.50%
0.01
52.92%
-0.01
177.97%
0.03
691.36%
sales general and administrative to revenue
shareholders equity per share
22.01
-
27.28
23.92%
31.53
15.61%
35.63
12.99%
35.32
0.87%
42.09
19.16%
43.70
3.82%
41.93
4.04%
47.72
13.79%
52.68
10.40%
stock based compensation to revenue
0.00
-
0.00
42.25%
0.00
37.02%
0.00
128.84%
0.00
56.23%
0.00
75.33%
0.00
82.45%
-0.11
93,299.06%
-0.10
9.65%
0.02
-
tangible asset value
-2.12B
-
-3.23B
51.99%
-3.08B
4.54%
-2.91B
5.62%
-1.96B
32.60%
11M
100.56%
-2.22B
20,254.55%
-2.01B
9.38%
-1.84B
8.31%
-1.86B
1.03%
-1.19B
36.28%
tangible book value per share
-6.99
-
-10.67
52.75%
-10.12
5.21%
-9.51
6.04%
-6.39
32.78%
0.04
100.56%
-7.32
20,390.88%
-6.83
6.72%
-6.29
7.95%
-6.35
0.92%
working capital
1.98B
-
2.67B
34.96%
2.56B
4.17%
2.16B
15.42%
1.07B
50.38%
1.58B
46.98%
157.77M
90.01%
1.11B
606.74%
709M
36.41%
1.74B
144.85%
2.59B
49.18%

All numbers in (except ratios and percentages)